Statistics

Total Visits

Views
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia25

Select a period of time:

Number of views in the range

Views
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia17

Views

Views
January 20250
February 20250
March 202515
April 20252
May 20250
June 20250
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
Spain1
United States1
 

Top cities views

Views
Council Bluffs1